Insulin-like growth factor-1 (IGF-1) empowering tendon regenerative therapies
Tendon injury is one of the most common musculoskeletal disorders that severely affect patients’ daily lives. Unfortunately, naturally healed tendons exhibit poor quality, as they have very limited regenerative ability. Recently, therapeutic strategies involving the administration of growth factors...
Saved in:
| Main Authors: | Mingming Wang, Jiayuan Zhang, Hanyue Li, Yini Li, Zhigang Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2025.1492811/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seahorse-assessed metabolic data, CAM assay data and aspect ratio data of tenocyte in vitro cultures treated with insulin-like growth factor-1 (IGF-1), with platelet-derived growth factor-BB (PDGF-BB) or with IGF-1 and PDGF-BB simultaneouslyMendeley DataMendeley DataMendeley Data
by: Julia Rieber, et al.
Published: (2025-10-01) -
Therapeutic potential of GDF-5 for enhancing tendon regenerative healing
by: Hanyue Li, et al.
Published: (2024-06-01) -
Fluoroquinolone-Mediated Tendinopathy and Tendon Rupture
by: Ezgi Duman, et al.
Published: (2025-01-01) -
Optimizing Flexor Digitorum Profundus Tendon Repair: A Narrative Review
by: Rishith R. Mereddy, et al.
Published: (2025-03-01) -
Current Concepts in Acute Achilles Tendon Injury
by: Amit Bishnoi, et al.
Published: (2022-07-01)